Ansh Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.49 M
as on 16-11-2024
- Revenue 152.35%
(FY 2023)
- Profit 220.40%
(FY 2023)
- Ebitda 183.32%
(FY 2023)
- Net Worth 76.03%
(FY 2023)
- Total Assets 61.50%
(FY 2023)
About Ansh Therapeutics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.49 M.
Sandeep Bajaj and Harpreet Bajaj serve as directors at the Company.
- CIN/LLPIN
U33110DL2010PTC204655
- Company No.
204655
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ansh Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Bajaj  | Director | 24-Jun-2010 | Current |
| Harpreet Bajaj | Director | 24-Jun-2010 | Current |
Financial Performance of Ansh Therapeutics.
Ansh Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 152.35% increase. The company also saw a substantial improvement in profitability, with a 220.4% increase in profit. The company's net worth Soared by an impressive increase of 76.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ansh Therapeutics?
In 2023, Ansh Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹7.49 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2021 | Hdfc Bank Limited | ₹7.49 M | Open |
How Many Employees Work at Ansh Therapeutics?
Unlock and access historical data on people associated with Ansh Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ansh Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ansh Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.